skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: HI there,

Two part question here. First, why is EXAS (in your opinion) being crushed so badly? It has fallen much more than GH. Something fundamentally wrong or one you would expect to bounce back hard and is thus worth adding to.

Secondly, would you suggest taking a 50% loss on EXAS to move to something like ABBV that pays a 7%+ dividend and seems safer? Jim Cramer advocates selling some stocks to move into more premium stocks that are also down and I'm wondering if this would be an example.

Please feel free to take 2 credits and provide complete answers to each part.
Read Answer Asked by Tim on March 19, 2020
Q: Hi Guys
Thanks for all your help during this little blip in the market. Thinking that with the new focus on Covid-19 treatment, medical supply companies might be a good investment, at least in terms of consumables. Do you think that might be a wise investment and if so do you have any favourites at this time?

Thanks

Stuart
Read Answer Asked by Stuart on March 17, 2020
Q: Do you know if Knight has re-purchased more shares since the monumental price decline?
Do you have any indication Medisen has reduced their share position from 10.4M shares?
Has Knight given any info on it's progress purchasing Biotoscan public shares?
Is this a good environment for JG to look for great bargains or will he let the dust settle and get their new acquisition going first?
Finally, is there a short position on Knight?
Whew! Thank you.
Read Answer Asked by Steven on March 16, 2020
Q: Hi folks,
In view of the coronavirus concerns, which are the companies you would recommend now as likely to grow strongly in the search for a vaccine or in the production of the equipment needed for fighting the spread of this virus ? Could you as well indicate the degree of risk involved in such companies and an order of priorities for the most interesting now ? As a start, what about GILD, INO, MRNA, REGN, SNY ?

Please deduct as many credits as you see fit.

And make sure you stay healthy…...we need you more than ever !

J. IDS
Read Answer Asked by Jacques on March 05, 2020
Q: 5i Team,

I'm curious what I'm missing in analyzing GUD? They're about a week or so away from reporting the first results of the acquisition, which should start to put them at a run rate of slightly less than $300M in revenues.
They should also have, once the dust clears have about $300M in cash left.

No debt, incredible growth, and a cash hoard for another major acquisition and it trades below book?

What am I missing?

Thanks!

Read Answer Asked by JAIME on March 05, 2020
Q: Hi there. It seems like in this Coronavirus hysteria nobody is excited about testing or treating cancer based on the trading of Guardant and Exact sciences. Do you like the current levels as a nice entry point for a speculative and long term position in each? It seems oversold unless I am missing a fundamental problem. To put a sharp point on the question, are they good buys today?

Thanks!
Read Answer Asked by Tim on March 04, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!